Joel Friedman, M.D., Ph.D., seated casually in his lab at Albert Einstein College of Medicine
Congratulations to Einstein's Joel Friedman, M.D., Ph.D. Vascarta, Inc, an Einstein start-up to advance his innovation has advanced his compound for treating #sicklecelldisease toward clinical trials. The #NlHLBI of the #NIH has signed a trial agreement with Vascarta. More at prn.to/45XXcMA. #MedSky
1
0
0
1